Atlas Trials

NovoCure GmbH

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NovoCure GmbH

RecordFirmDate
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma (NCT06556563)NovoCure GmbH2025-02-03
LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT06558799)NovoCure GmbH2024-10-14
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC (NCT06216301)NovoCure GmbH2024-07-31
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer (NCT04892472)NovoCure GmbH2021-07-12
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM (NCT04492163)NovoCure GmbH2020-07-14

Track NovoCure GmbH automatically

Every clearance here is in the API, with alerts when new ones post.